Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion

Detalles Bibliográficos
Autores principales: Cai, Cun-Liang, Zhang, Ming-Qiang, Guo, Jun, Wang, Li-Wan, Zhao, Jing-Quan, Guo, Wen-Jia, Mu, Xiang-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964956/
https://www.ncbi.nlm.nih.gov/pubmed/31833905
http://dx.doi.org/10.1097/CM9.0000000000000556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964956/
https://www.ncbi.nlm.nih.gov/pubmed/31833905
http://dx.doi.org/10.1097/CM9.0000000000000556

Ejemplares similares